Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Visualizing CAR-T Cell Therapy in Multiple Myeloma Using a BCMA-Targeted PET Probe

NCT07280793 is registered in ClinicalTrials.gov with Xuzhou Medical University as lead sponsor.

NCT NCT07280793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07280793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Visualizing CAR-T Cell Therapy in Multiple Myeloma Using a BCMA-Targeted PET Probe
Lead sponsor
Xuzhou Medical University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
December 17, 2025
Completion date
December 30, 2027
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bcma-targeted pet imaging, car-t cell biodistribution and persistence, gmp-compliant radiopharmaceutical preparation, non-invasive car-t cell monitoring